Compound Detail
CHEMBL5569341
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
Basic Information
| ChEMBL ID | CHEMBL5569341 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AUKKVCNLJWSWHO-VJVRTMNHSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
1313.7
MW (Da)
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38762978 | 10.1016/j.bmc.2024.117760 | A20 | 1 |
| 38762978 | 10.1016/j.bmc.2024.117760 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine